What Is Quality by Design and Why It Matters for Icelandic PharmaUntitledA Science-Based Route to Consistent Quality
The Quality by Design Training in Iceland is a practical, one-day skills programme that teaches the Quality by Design (QbD) approach to pharmaceutical product and process development. QbD is a systematic, science-based way to build quality into a medicine from the design stage rather than testing it in at the end, and it is defined by the ICH Q8(R2) Pharmaceutical Development guideline alongside ICH Q9, Q10 and Q11. For professionals across Iceland's biosimilar, generic and medical device sector, from Alvotech and Coripharma to smaller CDMOs, this approach is now the expected foundation of modern development and of regulatory submissions to the EMA and FDA. The course shows you how to apply the core tools, the Quality Target Product Profile (QTPP), Critical Quality Attributes, risk assessment, Design of Experiments and the control strategy, to your own work. Delivered in live virtual and onsite formats by Invensis Learning, the training suits formulation scientists, process engineers, analytical scientists, and quality and regulatory professionals. You leave able to design quality in, reduce manufacturing risk and support stronger submissions, with skills you can use immediately.










